United States Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

November 2017 | 113 pages | ID: U8ED202ED55WEN
QYResearch

Abstracts

In this report, the United States Viral Vectors and Plasmid DNA Manufacturing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2012 to 2022 (forecast).

United States Viral Vectors and Plasmid DNA Manufacturing market competition by top manufacturers/players, with Viral Vectors and Plasmid DNA Manufacturing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aldevron
• Eurogentec
• Richter-Helm
• BioReliance
• Biovian
• Brammer Bio
• Cell and Gene Therapy Catapult
• Cobra Biologics
• FinVector
• FUJIFILM Diosynth Biotechnologies
• Lonza
• MassBiologics
• MolMed
• Oxford BioMedica
• Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
• Spark Therapeutics
• UniQure
• ViGene Biosciences
• Wuxi AppTec

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Plasmid DNA
• Viral Vectors
• Non-Viral Vectors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for each application, including

• Cancers
• Inherited Disorders
• Viral Infections
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

1 VIRAL VECTORS AND PLASMID DNA MANUFACTURING OVERVIEW

1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Product Category
  1.2.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Plasmid DNA
  1.2.4 Viral Vectors
  1.2.5 Non-Viral Vectors
1.3 United States Viral Vectors and Plasmid DNA Manufacturing Market by Application/End Users
  1.3.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancers
  1.3.3 Inherited Disorders
  1.3.4 Viral Infections
  1.3.5 Others
1.4 United States Viral Vectors and Plasmid DNA Manufacturing Market by Region
  1.4.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
  1.4.3 Southwest Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
  1.4.5 New England Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
  1.4.6 The South Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
  1.4.7 The Midwest Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)
  1.5.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
  1.5.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

2 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Viral Vectors and Plasmid DNA Manufacturing Average Price by Players/Suppliers (2012-2017)
2.4 United States Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
  2.4.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
  2.4.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Viral Vectors and Plasmid DNA Manufacturing Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Region (2012-2017)
3.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Region (2012-2017)
3.3 United States Viral Vectors and Plasmid DNA Manufacturing Price by Region (2012-2017)

4 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
4.3 United States Viral Vectors and Plasmid DNA Manufacturing Price by Type (2012-2017)
4.4 United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application (2012-2017)
5.2 United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aldevron
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eurogentec
  6.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Richter-Helm
  6.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 BioReliance
  6.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biovian
  6.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Brammer Bio
  6.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cell and Gene Therapy Catapult
  6.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cobra Biologics
  6.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 FinVector
  6.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 FUJIFILM Diosynth Biotechnologies
  6.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Lonza
6.12 MassBiologics
6.13 MolMed
6.14 Oxford BioMedica
6.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
6.16 Spark Therapeutics
6.17 UniQure
6.18 ViGene Biosciences
6.19 Wuxi AppTec

7 VIRAL VECTORS AND PLASMID DNA MANUFACTURING MANUFACTURING COST ANALYSIS

7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Forecast by Type (2017-2022)
11.3 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Forecast by Application (2017-2022)
11.4 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Size () by Type (2012-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Market Share by Type (Product Category) in 2016
Figure Plasmid DNA Product Picture
Figure Viral Vectors Product Picture
Figure Non-Viral Vectors Product Picture
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Size () by Application (2012-2022)
Figure United States Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application in 2016
Figure Cancers Examples
Figure Inherited Disorders Examples
Figure Viral Infections Examples
Figure Others Examples
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Size (Million USD) by Region (2012-2022)
Figure The West Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Major Players Product Sales Volume () (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales () of Key Players/Suppliers (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Players/Suppliers
Figure 2017 United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Players/Suppliers
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players/Suppliers
Figure 2017 United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players/Suppliers
Table United States Market Viral Vectors and Plasmid DNA Manufacturing Average Price () of Key Players/Suppliers (2012-2017)
Figure United States Market Viral Vectors and Plasmid DNA Manufacturing Average Price () of Key Players/Suppliers in 2016
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Players/Suppliers
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Viral Vectors and Plasmid DNA Manufacturing Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Viral Vectors and Plasmid DNA Manufacturing Product Category
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales () by Region (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Region (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Region (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Region in 2016
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Region (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region in 2016
Table United States Viral Vectors and Plasmid DNA Manufacturing Price () by Region (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales () by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Type (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Type (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type in 2016
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type in 2016
Table United States Viral Vectors and Plasmid DNA Manufacturing Price () by Types (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales () by Application (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application in 2016
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2012-2017)
Table Aldevron Basic Information List
Table Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Eurogentec Basic Information List
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Richter-Helm Basic Information List
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table BioReliance Basic Information List
Table BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Biovian Basic Information List
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Biovian Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Biovian Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Brammer Bio Basic Information List
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Cell and Gene Therapy Catapult Basic Information List
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Cobra Biologics Basic Information List
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table FinVector Basic Information List
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table FUJIFILM Diosynth Biotechnologies Basic Information List
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate (2012-2017)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in United States (2012-2017)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in United States (2012-2017)
Table Lonza Basic Information List
Table MassBiologics Basic Information List
Table MolMed Basic Information List
Table Oxford BioMedica Basic Information List
Table Sanofi (CEPiA, Sanofi Pasteur, Genzyme) Basic Information List
Table Spark Therapeutics Basic Information List
Table UniQure Basic Information List
Table ViGene Biosciences Basic Information List
Table Wuxi AppTec Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing
Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
Table Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Players/Suppliers in 2016
Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing
Table Distributors/Traders List
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () and Growth Rate Forecast (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Price () Trend Forecast (2017-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Type (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Type (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Type in 2022
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Application (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Application (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Application in 2022
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume () Forecast by Region (2017-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Share Forecast by Region (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Share Forecast by Region (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources